View Grant Opportunity
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
RFA-CA-27-020
HHS-NIH11
General Information
$2,600,000
Est. Program Funding:
Est. Program Funding:
October 19, 2026
Closing Date:
Closing Date:
3
Expected No. of Awards
Expected No. of Awards
$600,000
Award Ceiling
Award Ceiling
Opportunity Number:
RFA-CA-27-020
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| This Notice of Funding Opportunity (NOFO) invites applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on advancing emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. To be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving cancer research projects as well as the broader user community throughout the development process must be included.This NOFO invites applications for the enhancement and dissemination of emerging, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis is on uniqueness and potential impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:Potential to advance driving cancer research projects and the cancer research field in general;Offers clear advantages over competing technologies in the targeted cancer research domain;Provides compelling plans and processes for supporting and engaging end users to evaluate and apply the tool or resource;Provides plans for advancing use of the tool or resource by the targeted community through collaboration, outreach, and training;Provides a realistic timeline and milestones for technology development. | |
| Response Date | Oct 19, 2026 12:00:00 AM EDT |
| Posting Date | May 21, 2026 12:00:00 AM EDT |
| Archive Date | Dec 19, 2026 12:00:00 AM EST |
| Award Ceiling | 600,000 |
| Award Floor | 50,000 |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | City or township governments, Others (see text field entitled "Additional Information on Eligibility" for clarification), State governments, Native American tribal organizations (other than Federally recognized tribal governments), Independent school districts, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal governments (Federally recognized), County governments, Private institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Public and State controlled institutions of higher education, For profit organizations other than small businesses, Public housing authorities/Indian housing authorities, Special district governments, Small businesses |
| Additional Info on Eligibility: | Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | N/a |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.393: Cancer Cause and Prevention Research
- 93.394: Cancer Detection and Diagnosis Research
- 93.395: Cancer Treatment Research
- 93.396: Cancer Biology Research
- 93.399: Cancer Control
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.